1. "Heiko Schoder"
Formats
  1. Journal Article (263)
  2. Meeting Abstract (199)
  3. Book Section (31)
  4. Review (18)
  5. Editorial (14)
  6. Guidelines (8)
  7. Research Letter (6)
  8. Miscellaneous (3)
  9. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)

More Groups

People
  1. Heiko Schoder (543)
  2. John Humm (96)
  3. Steven Larson (93)
  4. Andrew Zelenetz (66)
  5. Nancy Lee (65)
  6. Alison Moskowitz (59)

More People

Years
  1. 2025 (11)
  2. 2024 (36)
  3. 2023 (42)
  4. 2022 (40)
  5. 2021 (51)
  6. 2020 (30)

More Years

Publications
  1. Journal of Nuclear Medicine (94)
  2. Journal of Clinical Oncology (60)
  3. Blood (59)
  4. International Journal of Radiation Oncology, Biology, Physics (41)
  5. European Journal of Nuclear Medicine and Molecular Imaging (38)
  6. Hematological Oncology (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (94)
  2. Springer (78)
  3. Elsevier Inc. (67)
  4. American Society of Hematology (65)
  5. American Society of Clinical Oncology (60)
  6. Lippincott Williams & Wilkins (22)

More Publishers

Results (543)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Uptake of [(18)F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma
    Journal Article

    Qi, S.; Huang, M. Y.; Yang, Y.; Schöder, H.; Teckie, S.; Noy, A.; Chau, K.; Yahalom, J.
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Predicting hypoxia status using a combination of contrast-enhanced computed tomography and (18)F-fluorodeoxyglucose positron emission tomography radiomics features
    Journal Article

    Crispin-Ortuzar, M.; Apte, A.; Grkovski, M.; Oh, J. H.; Lee, N. Y.; Schöder, H.; Humm, J. L.; Deasy, J. O.
    Radiotherapy and Oncology (2018)

    Fulltext@MSK | Save
  • Post-treatment/pre-operative PET response is not an independent predictor of outcomes for patients with gastric and GEJ adenocarcinoma
    Journal Article

    Hernandez, J. M.; Beylergil, V.; Goldman, D. A.; van Beek, E.; Gonen, M.; Tang, L.; Downey, R.; Rizk, N.; Shah, M.; Strong, V.; more...
    Annals of Surgery (2018)

    Fulltext@MSK | Save
  • Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer
    Journal Article

    Fox, J. J.; Gavane, S. C.; Blanc-Autran, E.; Nehmeh, S.; Gonen, M.; Beattie, B.; Vargas, H. A.; Schoder, H.; Humm, J. L.; Fine, S. W.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics, biodistribution, and radiation dosimetry for (89)Zr-trastuzumab in patients with esophagogastric cancer
    Journal Article

    O'Donoghue, J. A.; Lewis, J. S.; Pandit-Taskar, N.; Fleming, S. E.; Schöder, H.; Larson, S. M.; Beylergil, V.; Ruan, S.; Lyashchenko, S. K.; Zanzonico, P. B.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)
    Meeting Abstract

    Riaz, N.; Sherman, E. J.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J.; Singh, B.; Morris, L. G.; Wong, R. J.; Tsai, C. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Ironclad: A randomized phase III study of ibrutinib (Ibr) or no consolidation following autologous hematopoietic stem cell transplantation (AutoHCT) for relapsed/refractory activated-B-cell (ABC) subtype diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Andreadis, C.; Fenske, T. S.; Hill, B. T.; Stiff, P. J.; Grinblatt, D. L.; Hsi, E. D.; Kelley, T.; Richards, K. L.; Kostakoglu, L.; Schoder, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Teaching cases in nuclear oncology: Lymphomas
    Book Section

    Ito, K.; Gavane, S.; Schöder, H.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (2017)

    Fulltext@MSK | Save
  • Teaching cases in nuclear oncology: Multiple myeloma
    Book Section

    Ito, K.; Gavane, S.; Schöder, H.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (2017)

    Fulltext@MSK | Save